Literature DB >> 19116202

Normal hepatic cell surface localization of the high density lipoprotein receptor, scavenger receptor class B, type I, depends on all four PDZ domains of PDZK1.

Sara A Fenske1, Ayce Yesilaltay, Rinku Pal, Kathleen Daniels, Caroline Barker, Verónica Quiñones, Attilio Rigotti, Monty Krieger, Olivier Kocher.   

Abstract

PDZK1 is a four PDZ domain-containing scaffold protein that binds to scavenger receptor class B, type I (SR-BI), the high density lipoprotein receptor, by its first PDZ domain (PDZ1). PDZK1 knock-out mice exhibit a >95% decrease in hepatic SR-BI protein and consequently an approximately 70% increase in plasma cholesterol in abnormally large high density lipoprotein particles. These defects are corrected by hepatic overexpression of full-length PDZK1 but not the PDZ1 domain alone, which partially restores SR-BI protein abundance but not cell surface expression or function. We have generated PDZK1 knock-out mice with hepatic expression of four PDZK1 transgenes encoding proteins with nested C-terminal truncations: pTEM, which lacks the three C-terminal residues (putative PDZ-binding motif), and PDZ1.2, PDZ1.2.3, or PDZ1.2.3.4, which contain only the first two, three, or four N-terminal PDZ domains, respectively, but not the remaining C-terminal sequences. Hepatic overexpression of pTEM restored normal hepatic SR-BI abundance, localization, and function. Hepatic overexpression of PDZ1.2 or PDZ1.2.3 partially restored SR-BI abundance ( approximately 12 or approximately 30% of wild type, respectively) but did not (PDZ1.2) or only slightly (PDZ1.2.3) restored hepatic SR-BI cell surface localization and function. Hepatic overexpression of PDZ1.2.3.4 completely restored SR-BI protein abundance, cell surface expression, and function (normalization of plasma cholesterol levels). Thus, all four PDZ domains in PDZK1, but not PDZ1-3 alone, are sufficient for its normal control of the abundance, localization, and therefore function of hepatic SR-BI, whereas the residues C-terminal to the PDZ4 domain, including the C-terminal putative PDZ-binding domain, are not required.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116202      PMCID: PMC2645830          DOI: 10.1074/jbc.M808211200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism.

Authors:  Olivier Kocher; Ayce Yesilaltay; Christine Cirovic; Rinku Pal; Attilio Rigotti; Monty Krieger
Journal:  J Biol Chem       Date:  2003-10-08       Impact factor: 5.157

2.  PDZK1: I. a major scaffolder in brush borders of proximal tubular cells.

Authors:  Serge M Gisler; Sandra Pribanic; Desa Bacic; Patrik Forrer; Andrea Gantenbein; Luc A Sabourin; Akira Tsuji; Zhuo-Shen Zhao; Edward Manser; Jürg Biber; Heini Murer
Journal:  Kidney Int       Date:  2003-11       Impact factor: 10.612

3.  Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I.

Authors:  M Ikemoto; H Arai; D Feng; K Tanaka; J Aoki; N Dohmae; K Takio; H Adachi; M Tsujimoto; K Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse.

Authors:  Anne Braun; Songwen Zhang; Helena E Miettinen; Shamsah Ebrahim; Teresa M Holm; Eliza Vasile; Mark J Post; Danita M Yoerger; Michael H Picard; Joshua L Krieger; Nancy C Andrews; Michael Simons; Monty Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-27       Impact factor: 11.205

Review 5.  The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues.

Authors:  Attilio Rigotti; Helena E Miettinen; Monty Krieger
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

6.  Overexpression of SR-BI by adenoviral vector reverses the fibrateinduced hypercholesterolemia of apolipoprotein E-deficient mice.

Authors:  Tao Fu; Karen F Kozarsky; Jayme Borensztajn
Journal:  J Biol Chem       Date:  2003-10-21       Impact factor: 5.157

7.  Targeted disruption of the PDZK1 gene by homologous recombination.

Authors:  Olivier Kocher; Rinku Pal; Mark Roberts; Christine Cirovic; Annalyn Gilchrist
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

8.  Overexpression of the PDZ1 domain of PDZK1 blocks the activity of hepatic scavenger receptor, class B, type I by altering its abundance and cellular localization.

Authors:  Sara A Fenske; Ayce Yesilaltay; Rinku Pal; Kathleen Daniels; Attilio Rigotti; Monty Krieger; Olivier Kocher
Journal:  J Biol Chem       Date:  2008-06-10       Impact factor: 5.157

9.  A carboxyl-terminal PDZ-interacting domain of scavenger receptor B, type I is essential for cell surface expression in liver.

Authors:  David L Silver
Journal:  J Biol Chem       Date:  2002-07-15       Impact factor: 5.157

10.  Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver.

Authors:  Miranda Van Eck; Jaap Twisk; Menno Hoekstra; Brechje T Van Rij; Christian A C Van der Lans; I Sophie T Bos; J Kar Kruijt; Folkert Kuipers; Theo J C Van Berkel
Journal:  J Biol Chem       Date:  2003-03-14       Impact factor: 5.157

View more
  20 in total

1.  PDZK1 binding and serine phosphorylation regulate subcellular trafficking of organic anion transport protein 1a1.

Authors:  Jo H Choi; John W Murray; Allan W Wolkoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-23       Impact factor: 4.052

2.  Noncanonical role of the PDZ4 domain of the adaptor protein PDZK1 in the regulation of the hepatic high density lipoprotein receptor scavenger receptor class B, type I (SR-BI).

Authors:  Kosuke Tsukamoto; Thomas E Wales; Kathleen Daniels; Rinku Pal; Ren Sheng; Wonhwa Cho; Walter Stafford; John R Engen; Monty Krieger; Olivier Kocher
Journal:  J Biol Chem       Date:  2013-05-17       Impact factor: 5.157

Review 3.  Scavenger receptor class B type I (SR-BI): a versatile receptor with multiple functions and actions.

Authors:  Wen-Jun Shen; Jie Hu; Zhigang Hu; Fredric B Kraemer; Salman Azhar
Journal:  Metabolism       Date:  2014-03-21       Impact factor: 8.694

Review 4.  Update on HDL receptors and cellular cholesterol transport.

Authors:  Ginny Kellner-Weibel; Margarita de la Llera-Moya
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

Review 5.  Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function.

Authors:  Wen-Jun Shen; Shailendra Asthana; Fredric B Kraemer; Salman Azhar
Journal:  J Lipid Res       Date:  2018-05-02       Impact factor: 5.922

6.  Na⁺/H⁺ exchanger regulatory factor 3 is critical for multidrug resistance protein 4-mediated drug efflux in the kidney.

Authors:  Joonhee Park; Jin-Oh Kwak; Brigitte Riederer; Ursula Seidler; Susan P C Cole; Hwa Jeong Lee; Min Goo Lee
Journal:  J Am Soc Nephrol       Date:  2014-01-16       Impact factor: 10.121

7.  Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones.

Authors:  Jie Hu; Zhonghua Zhang; Wen-Jun Shen; Salman Azhar
Journal:  Nutr Metab (Lond)       Date:  2010-06-01       Impact factor: 4.169

8.  The SR-BI partner PDZK1 facilitates hepatitis C virus entry.

Authors:  Nicholas S Eyre; Heidi E Drummer; Michael R Beard
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

9.  Regulation of expression and function of scavenger receptor class B, type I (SR-BI) by Na+/H+ exchanger regulatory factors (NHERFs).

Authors:  Zhigang Hu; Jie Hu; Zhonghua Zhang; Wen-Jun Shen; C Chris Yun; Catherine H Berlot; Fredric B Kraemer; Salman Azhar
Journal:  J Biol Chem       Date:  2013-03-12       Impact factor: 5.157

10.  MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells.

Authors:  Zhigang Hu; Wen-Jun Shen; Fredric B Kraemer; Salman Azhar
Journal:  Mol Cell Biol       Date:  2012-10-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.